Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 2/20 | 0.52 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.48 |
| ▸ | GHSR | Q92847 | 2/20 | 0.47 |
| ▸ | CALCRL | Q16602 | 4/20 | 0.46 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL760888 | 0.88 | MMP2 (0.55) | F10MTNR1AGHSRCALCRLTACR1 | |
| SCHEMBL737041 | 0.83 | GHSR (0.70) | F10MTNR1AGHSRCALCRLTACR1 | |
| SCHEMBL737028 | 0.83 | GHSR (0.70) | F10MTNR1AGHSRCALCRLTACR1 | |
| SCHEMBL14615562 | 0.83 | GHSR (0.51) | F10MTNR1AGHSRCALCRLTACR1 | |
| SCHEMBL762149 | 0.81 | GHSR (0.49) | GHSRTACR1MMP9 | |
| SCHEMBL736820 | 0.81 | GHSR (0.49) | F10MTNR1AGHSRCALCRLTACR1 | |
| SCHEMBL737999 | 0.80 | GHSR (0.49) | F10MTNR1AGHSRCALCRLTACR1 | |
| SCHEMBL761165 | 0.80 | F10 (0.52) | F10GHSRCALCRLTACR1CYP2A6 | |
| SCHEMBL762665 | 0.80 | GHSR (0.71) | F10GHSR | |
| SCHEMBL739284 | 0.78 | GHSR (0.63) | MTNR1AGHSRCALCRLTACR1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138218-B2 | Growth hormone secretagogues | IPSEN PHARMA S.A.S. (FR) | 2012-03-20 | — | — | US | disclosed |
| US-20090131478-A1 | Growth Hormone Secretagogues | IPSEN PHARMA S.A.S. (FR) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131478-A1 | Growth Hormone Secretagogues | GHSR, GHRHR, GHITM | F10 2410/4885MTNR1A 478/4885GHSR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.